Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.
Saved in:
| Title: | Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. |
|---|---|
| Authors: | Vranic S; College of Medicine, QU Health, Qatar University, Doha, Qatar; Department of Medical Sciences, Academy of Sciences and Arts of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina. semir.vranic@gmail.com; svranic@qu.edu.qa., Basu GD; Exact Sciences, Phoenix, Arizona, United States of America., Hall DW; Exact Sciences, Phoenix, Arizona, United States of America., Gatalica Z; Exact Sciences, Phoenix, Arizona, United States of America; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America. |
| Source: | Acta medica academica [Acta Med Acad] 2022 Dec; Vol. 51 (3), pp. 217-231. Date of Electronic Publication: 2022 Dec 30. |
| Publication Type: | Review; Journal Article |
| Journal Info: | Publisher: Akademija nauka i umjetnosti Bosne i Hercegovine Country of Publication: Bosnia and Herzegovina NLM ID: 101587903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1840-2879 (Electronic) Linking ISSN: 18401848 NLM ISO Abbreviation: Acta Med Acad Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1840-2879 |
|---|---|
| DOI: | 10.5644/ama2006-124.392 |
